Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Kuhlik Bruce N
   2. Issuer Name and Ticker or Trading Symbol
Merck & Co. Inc. [MRK] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Exec. V.P. and General Counsel
(Last)
(First)
(Middle)
ONE MERCK DRIVE		 3. Date of Earliest Transaction (Month/Day/Year)
11/03/2009
(Street)

WHITEHOUSE STATION, NJ 08889-0100		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/03/2009   A   17,660.0888 A $ 0 (1) 0 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit (2) 11/03/2009   A   4,500   03/02/2010(2) 03/02/2010(2) Common Stock 4,500 $ 0 0 D  
Restricted Stock Unit (2) 11/03/2009   A   15,000   08/01/2010(2) 08/01/2010(2) Common Stock 15,000 $ 0 0 D  
Restricted Stock Unit (2) 11/03/2009   A   11,700   02/28/2011(2) 02/28/2011(2) Common Stock 11,700 $ 0 0 D  
Restricted Stock Unit (2) 11/03/2009   A   13,650   04/24/2012(2) 04/24/2012(2) Common Stock 13,650 $ 0 0 D  
RSU - Leader Shares (2) 11/03/2009   A   3,700   02/01/2010(2) 02/01/2010(2) Common Stock 3,700 $ 0 0 D  
RSU - Leader Shares (2) 11/03/2009   A   6,000   02/28/2011(2) 02/28/2011(2) Common Stock 6,000 $ 0 0 D  
Stock Option (right to buy) $ 32.72 11/03/2009   A   10,000   05/23/2006(3) 05/22/2015 Common Stock 10,000 $ 0 (3) 0 D  
Stock Option (right to buy) $ 34.47 11/03/2009   A   500   02/01/2007(3) 01/31/2016 Common Stock 500 $ 0 (3) 0 D  
Stock Option (right to buy) $ 35.09 11/03/2009   A   20,880   03/03/2007(3) 03/02/2016 Common Stock 20,880 $ 0 (3) 0 D  
Stock Option (right to buy) $ 44.19 11/03/2009   A   24,000   03/02/2008(3) 03/01/2017 Common Stock 24,000 $ 0 (3) 0 D  
Stock Option (right to buy) $ 51.02 11/03/2009   A   50,000   08/01/2008(3) 07/31/2017 Common Stock 50,000 $ 0 (3) 0 D  
Stock Option (right to buy) $ 44.3 11/03/2009   A   62,400   02/28/2009(3) 02/28/2018 Common Stock 62,400 $ 0 (3) 0 D  
Stock Option (right to buy) $ 23.45 11/03/2009   A   72,800   04/24/2010(3) 04/23/2019 Common Stock 72,800 $ 0 (3) 0 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Kuhlik Bruce N
ONE MERCK DRIVE
WHITEHOUSE STATION, NJ 08889-0100		       Exec. V.P. and General Counsel  

Signatures

 Debra A. Bollwage as Attorney-in-Fact for Bruce N. Kuhlik   11/05/2009
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Received in exchange for an equivalent number of shares of Merck Sharp & Dohme Corp. (formerly Merck & Co., Inc.) ("MSD") common stock in connection with the completion of transactions contemplated by the Agreement and Plan of Merger by and among, inter alia, MSD and Merck & Co., Inc. (formerly Schering-Plough Corporation) (the "Transactions").
(2) Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule.
(3) This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.